| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918154 | Radiotherapy and Oncology | 2015 | 10 Pages |
Abstract
Both FFS and PFS could be valid surrogate endpoints for OS in trials of combined chemotherapy and radiotherapy for NPC; PFS may be a more acceptable surrogate endpoint compared with FFS.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yu-Pei Chen, Ying Sun, Lei Chen, Yan-Ping Mao, Ling-Long Tang, Wen-Fei Li, Xu Liu, Wen-Na Zhang, Guan-Qun Zhou, Rui Guo, Ai-Hua Lin, Jun Ma,